TAE Life Sciences Revenue and Competitors

Foothill Ranch,

Location

$70M

Total Funding

Estimated Revenue & Valuation

  • TAE Life Sciences's estimated annual revenue is currently $17.4M per year.(i)
  • TAE Life Sciences's estimated revenue per employee is $234,900
  • TAE Life Sciences's total funding is $70M.

Employee Data

  • TAE Life Sciences has 74 Employees.(i)
  • TAE Life Sciences grew their employee count by 28% last year.

TAE Life Sciences's People

NameTitleEmail/Phone
1
Chief Science OfficerReveal Email/Phone
2
Global VP Marketing and StrategyReveal Email/Phone
3
CEOReveal Email/Phone
4
CEOReveal Email/Phone
5
VP OperationsReveal Email/Phone
6
VP Business Development, EMEAReveal Email/Phone
7
VP Business Development EMEAReveal Email/Phone
8
Director Software EngineeringReveal Email/Phone
9
Director, Molecular BiologyReveal Email/Phone
10
Senior Director Protein SciencesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$54.4M1836%N/AN/A
#2
$18M74-4%N/AN/A
#3
$162.7M48239%N/AN/A
#4
$42.8M1448%N/AN/A
#5
$26.5M984%N/AN/A
#6
$33.2M123-2%N/AN/A
#7
$29.7M11012%N/AN/A
#8
$15.5M66-21%$29.7MN/A
#9
$1645.8M435413%N/AN/A
#10
$43.7M14718%N/AN/A
Add Company

What Is TAE Life Sciences?

State-of-the-art biotechnology company enabling convenient clinical access to Boron Neutron Capture Therapy (BNCT), a promising, previously inaccessible cancer treatment.

keywords:N/A

$70M

Total Funding

74

Number of Employees

$17.4M

Revenue (est)

28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TAE Life Sciences News

2020-06-03 - TAE Life Sciences Finds $30M In Series B Round

Foothill Ranch-based TAE Life Sciences, which is developing boron-based radiation therapy drugs for the treatment of cancer, has raised $30M in what it says is an initial, Series B funding round. The company said the funding comes from a consortium of investors, including ARTIS Ventures. The com ...

2020-06-02 - TAE Life Sciences Raises $30M in Initial Series B Funding

Tae Life Sciences, a Foothill Ranch, Calif.-based biological-targeting radiation therapy company developing boron neutron capture therapy solutions, raised $30M in funding. The initial phase of the B-round funds come from a consortium of investors including Artis Ventures, who led the company’s ...

2018-03-12 - TAE Life Sciences Raises $40M in Venture Capital Funding

TAE Life Sciences, a Foothill Ranch, CA-based medical technology company developing an accelerator-based platform for clinical investigation of a promising, previously inaccessible cancer treatment, raised $40m in venture capital funding. The round was led by Artis Ventures. TAE Life Sciences, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12M83-1%N/A
#2
$18.1M869%N/A
#3
$26.1M9023%N/A
#4
$20.4M975%N/A
#5
$21.8M1043%N/A